Tech Company Financing Transactions

Semma Therapeutics Funding Round

On 12/1/2017, Semma Therapeutics raised $114 million in Series B funding from Cowen Capital Partners, Eight Roads and 6 Dimensions Capital.

Transaction Overview

Company Name
Semma Therapeutics
Announced On
12/1/2017
Transaction Type
Venture Equity
Amount
$114,000,000
Round
Series B
Investors

Cowen Capital Partners (Lead Investor) (Kevin Raidy)

Eight Roads (Lead Investor) (Daniel Auerbach)

6 Dimensions Capital

Arch Venture Partners

F-Prime Capital (Steven Knight)

JDRF T1D Fund

Medtronic

MPM Capital (Robert Millman)

Novartis Venture Fund

ORI Healthcare Fund

SinoPharm Capital

Wu Capital

Proceeds Purpose
Proceeds will be used to bring Semma's lead development program, encapsulated stem cell-derived islets, through clinical proof-of-concept in patients and to continue exploration of other regenerative medicine therapeutics.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
450 Kendall St. 2B
Cambridge, MA 02142
USA
Phone
(857) 529-6430
Website
www.semma-tx.com
Email Address
Not Recorded
Overview
Semma Therapeutics was founded to develop transformative therapies for patients who currently depend on insulin injections.
Profile
Semma Therapeutics LinkedIn Company Profile
Social Media
Semma Therapeutics Company Twitter Account
Company News
Semma Therapeutics News
Facebook
Semma Therapeutics on Facebook
YouTube
Semma Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Bastiano Sanna
  Bastiano Sanna LinkedIn Profile  Bastiano Sanna Twitter Account  Bastiano Sanna News  Bastiano Sanna on Facebook
Chief Financial Officer
David Cordo
  David Cordo LinkedIn Profile  David Cordo Twitter Account  David Cordo News  David Cordo on Facebook
Chief Marketing Officer
Moses Goddard
  Moses Goddard LinkedIn Profile  Moses Goddard Twitter Account  Moses Goddard News  Moses Goddard on Facebook
Chief Technical Officer
David DiGiusto
  David DiGiusto LinkedIn Profile  David DiGiusto Twitter Account  David DiGiusto News  David DiGiusto on Facebook
Founder
Doug Melton
  Doug Melton LinkedIn Profile  Doug Melton Twitter Account  Doug Melton News  Doug Melton on Facebook
Vice President
Jason Gaglia
  Jason Gaglia LinkedIn Profile  Jason Gaglia Twitter Account  Jason Gaglia News  Jason Gaglia on Facebook
Vice President
Christopher Thanos
  Christopher Thanos LinkedIn Profile  Christopher Thanos Twitter Account  Christopher Thanos News  Christopher Thanos on Facebook
VP - Operations
Jeffrey Imbaro
  Jeffrey Imbaro LinkedIn Profile  Jeffrey Imbaro Twitter Account  Jeffrey Imbaro News  Jeffrey Imbaro on Facebook
VP - R & D
Felicia Pagliuca
  Felicia Pagliuca LinkedIn Profile  Felicia Pagliuca Twitter Account  Felicia Pagliuca News  Felicia Pagliuca on Facebook

 

 

Browse more venture capital transactions:

Prev: 12/1/2017: Mojio venture capital transaction
Next: 12/1/2017: TetraVue venture capital transaction

 

Share this article

 

About Database of VC Transactions

We do our best to record tech company VC transactions. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.